Description
To determine the efficacy of Lenstatin™, an over-the-counter nutritional supplement, in inhibiting the progression of nuclear cataract in eyes after pars plana vitrectomy.
Specialties:
- Physician Assistant: Clinical Pharmacology, Ophthalmology, Ophthalmology: Clinical Pharmacology, Refractive/Eye
- Surgery; Pharmacy: Other Drugs
- Sponsor: Lenstatin LLC
- Study Start Date: May 2014
Estimated Completion Date: December 2014
Interventions
- Dietary Supplement: Lenstatin
- Drug: Placebo
Inclusion Criteria
- Adults over the age of 18
- Post pars plana vitrectomy surgery
Exclusion Criteria
- Pediatric patients under the age of 18
- Pregnant women
- Hypersensitivity to any of the ingredients in Lenstatin
Study Locations And Contact Information
- Scott W Tunis MD FACS, Wilmington North Carolina
Learn more: http://www.mdlinx.com/ophthalmology/clinical-trials/clinical-trial-detail.cfm?NCT_ID=NCT02131194